0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Delivery Soft Mist Inhalers Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-23Z16980
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Drug Delivery Soft Mist Inhalers Market Research Report 2024
BUY CHAPTERS

Global Drug Delivery Soft Mist Inhalers Market Research Report 2024

Code: QYRE-Auto-23Z16980
Report
May 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Delivery Soft Mist Inhalers Market Size

The global Drug Delivery Soft Mist Inhalers market was valued at US$ 2620 million in 2023 and is anticipated to reach US$ 4165 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.

Drug Delivery Soft Mist Inhalers Market

Drug Delivery Soft Mist Inhalers Market

A recent development in inhaler technology has been the development of low-velocity sprays known as soft mist inhalers. These devices represent a new class of multidose inhaler devices and contain liquid formulations similar to those in nebulizers.
The growing incidence of chronic respiratory diseases, including asthma and COPD, along with the need for more effective inhalation delivery methods, is predicted to drive a fast growth in the global soft mist inhaler (Respimat, SMI) market in the following years. Growing demand for economically cost solutions and growing awareness of its advantages are expected to drive the SMI technology sector. Another factor predicted to boost market expansion is the launch of state-of-the-art and creative SMI products that provide patients with more comfort and convenience. For instance, by 2022, 11.7 million Americans, or 4.6% of the US population, will have chronic bronchitis, emphysema, or chronic obstructive lung disease.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Delivery Soft Mist Inhalers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Soft Mist Inhalers.
The Drug Delivery Soft Mist Inhalers market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drug Delivery Soft Mist Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Soft Mist Inhalers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Delivery Soft Mist Inhalers Market Report

Report Metric Details
Report Name Drug Delivery Soft Mist Inhalers Market
Accounted market size in 2023 US$ 2620 million
Forecasted market size in 2030 US$ 4165 million
CAGR 6.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Disposable
  • Reusable
Segment by Application
  • Hospitals and Clinics
  • Homecare Settings
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Recipharm (Resyca), Boehringer, Merxin Ltd, DSB Medical Co., Ltd., Aero Pump GmbH, Ursatec GmbH, 3M, Hovione, Mannkind, Meda, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Delivery Soft Mist Inhalers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Delivery Soft Mist Inhalers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Delivery Soft Mist Inhalers Market growing?

Ans: The Drug Delivery Soft Mist Inhalers Market witnessing a CAGR of 6.8% during the forecast period 2024-2030.

What is the Drug Delivery Soft Mist Inhalers Market size in 2030?

Ans: The Drug Delivery Soft Mist Inhalers Market size in 2030 will be US$ 4165 million.

Who are the main players in the Drug Delivery Soft Mist Inhalers Market report?

Ans: The main players in the Drug Delivery Soft Mist Inhalers Market are Recipharm (Resyca), Boehringer, Merxin Ltd, DSB Medical Co., Ltd., Aero Pump GmbH, Ursatec GmbH, 3M, Hovione, Mannkind, Meda, Novartis

What are the Application segmentation covered in the Drug Delivery Soft Mist Inhalers Market report?

Ans: The Applications covered in the Drug Delivery Soft Mist Inhalers Market report are Hospitals and Clinics, Homecare Settings, Others

What are the Type segmentation covered in the Drug Delivery Soft Mist Inhalers Market report?

Ans: The Types covered in the Drug Delivery Soft Mist Inhalers Market report are Disposable, Reusable

1 Drug Delivery Soft Mist Inhalers Market Overview
1.1 Product Definition
1.2 Drug Delivery Soft Mist Inhalers by Type
1.2.1 Global Drug Delivery Soft Mist Inhalers Market Value Comparison by Type (2024-2030)
1.2.2 Disposable
1.2.3 Reusable
1.3 Drug Delivery Soft Mist Inhalers by Application
1.3.1 Global Drug Delivery Soft Mist Inhalers Market Value by Application (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Homecare Settings
1.3.4 Others
1.4 Global Drug Delivery Soft Mist Inhalers Market Size Estimates and Forecasts
1.4.1 Global Drug Delivery Soft Mist Inhalers Revenue 2019-2030
1.4.2 Global Drug Delivery Soft Mist Inhalers Sales 2019-2030
1.4.3 Global Drug Delivery Soft Mist Inhalers Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Delivery Soft Mist Inhalers Market Competition by Manufacturers
2.1 Global Drug Delivery Soft Mist Inhalers Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Delivery Soft Mist Inhalers Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Drug Delivery Soft Mist Inhalers, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Delivery Soft Mist Inhalers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Delivery Soft Mist Inhalers, Product Type & Application
2.7 Global Key Manufacturers of Drug Delivery Soft Mist Inhalers, Date of Enter into This Industry
2.8 Global Drug Delivery Soft Mist Inhalers Market Competitive Situation and Trends
2.8.1 Global Drug Delivery Soft Mist Inhalers Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Delivery Soft Mist Inhalers Players Market Share by Revenue
2.8.3 Global Drug Delivery Soft Mist Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Delivery Soft Mist Inhalers Market Scenario by Region
3.1 Global Drug Delivery Soft Mist Inhalers Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Delivery Soft Mist Inhalers Sales by Region: 2019-2030
3.2.1 Global Drug Delivery Soft Mist Inhalers Sales by Region: 2019-2024
3.2.2 Global Drug Delivery Soft Mist Inhalers Sales by Region: 2025-2030
3.3 Global Drug Delivery Soft Mist Inhalers Revenue by Region: 2019-2030
3.3.1 Global Drug Delivery Soft Mist Inhalers Revenue by Region: 2019-2024
3.3.2 Global Drug Delivery Soft Mist Inhalers Revenue by Region: 2025-2030
3.4 North America Drug Delivery Soft Mist Inhalers Market Facts & Figures by Country
3.4.1 North America Drug Delivery Soft Mist Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Delivery Soft Mist Inhalers Sales by Country (2019-2030)
3.4.3 North America Drug Delivery Soft Mist Inhalers Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Delivery Soft Mist Inhalers Market Facts & Figures by Country
3.5.1 Europe Drug Delivery Soft Mist Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Delivery Soft Mist Inhalers Sales by Country (2019-2030)
3.5.3 Europe Drug Delivery Soft Mist Inhalers Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Delivery Soft Mist Inhalers Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Delivery Soft Mist Inhalers Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Delivery Soft Mist Inhalers Sales by Region (2019-2030)
3.6.3 Asia Pacific Drug Delivery Soft Mist Inhalers Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Delivery Soft Mist Inhalers Market Facts & Figures by Country
3.7.1 Latin America Drug Delivery Soft Mist Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Delivery Soft Mist Inhalers Sales by Country (2019-2030)
3.7.3 Latin America Drug Delivery Soft Mist Inhalers Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Delivery Soft Mist Inhalers Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Delivery Soft Mist Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Delivery Soft Mist Inhalers Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Delivery Soft Mist Inhalers Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Delivery Soft Mist Inhalers Sales by Type (2019-2030)
4.1.1 Global Drug Delivery Soft Mist Inhalers Sales by Type (2019-2024)
4.1.2 Global Drug Delivery Soft Mist Inhalers Sales by Type (2025-2030)
4.1.3 Global Drug Delivery Soft Mist Inhalers Sales Market Share by Type (2019-2030)
4.2 Global Drug Delivery Soft Mist Inhalers Revenue by Type (2019-2030)
4.2.1 Global Drug Delivery Soft Mist Inhalers Revenue by Type (2019-2024)
4.2.2 Global Drug Delivery Soft Mist Inhalers Revenue by Type (2025-2030)
4.2.3 Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Type (2019-2030)
4.3 Global Drug Delivery Soft Mist Inhalers Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Delivery Soft Mist Inhalers Sales by Application (2019-2030)
5.1.1 Global Drug Delivery Soft Mist Inhalers Sales by Application (2019-2024)
5.1.2 Global Drug Delivery Soft Mist Inhalers Sales by Application (2025-2030)
5.1.3 Global Drug Delivery Soft Mist Inhalers Sales Market Share by Application (2019-2030)
5.2 Global Drug Delivery Soft Mist Inhalers Revenue by Application (2019-2030)
5.2.1 Global Drug Delivery Soft Mist Inhalers Revenue by Application (2019-2024)
5.2.2 Global Drug Delivery Soft Mist Inhalers Revenue by Application (2025-2030)
5.2.3 Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Application (2019-2030)
5.3 Global Drug Delivery Soft Mist Inhalers Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Recipharm (Resyca)
6.1.1 Recipharm (Resyca) Company Information
6.1.2 Recipharm (Resyca) Description and Business Overview
6.1.3 Recipharm (Resyca) Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Recipharm (Resyca) Drug Delivery Soft Mist Inhalers Product Portfolio
6.1.5 Recipharm (Resyca) Recent Developments/Updates
6.2 Boehringer
6.2.1 Boehringer Company Information
6.2.2 Boehringer Description and Business Overview
6.2.3 Boehringer Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Drug Delivery Soft Mist Inhalers Product Portfolio
6.2.5 Boehringer Recent Developments/Updates
6.3 Merxin Ltd
6.3.1 Merxin Ltd Company Information
6.3.2 Merxin Ltd Description and Business Overview
6.3.3 Merxin Ltd Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merxin Ltd Drug Delivery Soft Mist Inhalers Product Portfolio
6.3.5 Merxin Ltd Recent Developments/Updates
6.4 DSB Medical Co., Ltd.
6.4.1 DSB Medical Co., Ltd. Company Information
6.4.2 DSB Medical Co., Ltd. Description and Business Overview
6.4.3 DSB Medical Co., Ltd. Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DSB Medical Co., Ltd. Drug Delivery Soft Mist Inhalers Product Portfolio
6.4.5 DSB Medical Co., Ltd. Recent Developments/Updates
6.5 Aero Pump GmbH
6.5.1 Aero Pump GmbH Company Information
6.5.2 Aero Pump GmbH Description and Business Overview
6.5.3 Aero Pump GmbH Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aero Pump GmbH Drug Delivery Soft Mist Inhalers Product Portfolio
6.5.5 Aero Pump GmbH Recent Developments/Updates
6.6 Ursatec GmbH
6.6.1 Ursatec GmbH Company Information
6.6.2 Ursatec GmbH Description and Business Overview
6.6.3 Ursatec GmbH Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ursatec GmbH Drug Delivery Soft Mist Inhalers Product Portfolio
6.6.5 Ursatec GmbH Recent Developments/Updates
6.7 3M
6.7.1 3M Company Information
6.7.2 3M Description and Business Overview
6.7.3 3M Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.7.4 3M Drug Delivery Soft Mist Inhalers Product Portfolio
6.7.5 3M Recent Developments/Updates
6.8 Hovione
6.8.1 Hovione Company Information
6.8.2 Hovione Description and Business Overview
6.8.3 Hovione Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hovione Drug Delivery Soft Mist Inhalers Product Portfolio
6.8.5 Hovione Recent Developments/Updates
6.9 Mannkind
6.9.1 Mannkind Company Information
6.9.2 Mannkind Description and Business Overview
6.9.3 Mannkind Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mannkind Drug Delivery Soft Mist Inhalers Product Portfolio
6.9.5 Mannkind Recent Developments/Updates
6.10 Meda
6.10.1 Meda Company Information
6.10.2 Meda Description and Business Overview
6.10.3 Meda Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Meda Drug Delivery Soft Mist Inhalers Product Portfolio
6.10.5 Meda Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Company Information
6.11.2 Novartis Description and Business Overview
6.11.3 Novartis Drug Delivery Soft Mist Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Novartis Drug Delivery Soft Mist Inhalers Product Portfolio
6.11.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Delivery Soft Mist Inhalers Industry Chain Analysis
7.2 Drug Delivery Soft Mist Inhalers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Delivery Soft Mist Inhalers Production Mode & Process
7.4 Drug Delivery Soft Mist Inhalers Sales and Marketing
7.4.1 Drug Delivery Soft Mist Inhalers Sales Channels
7.4.2 Drug Delivery Soft Mist Inhalers Distributors
7.5 Drug Delivery Soft Mist Inhalers Customers
8 Drug Delivery Soft Mist Inhalers Market Dynamics
8.1 Drug Delivery Soft Mist Inhalers Industry Trends
8.2 Drug Delivery Soft Mist Inhalers Market Drivers
8.3 Drug Delivery Soft Mist Inhalers Market Challenges
8.4 Drug Delivery Soft Mist Inhalers Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drug Delivery Soft Mist Inhalers Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Drug Delivery Soft Mist Inhalers Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Drug Delivery Soft Mist Inhalers Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Drug Delivery Soft Mist Inhalers Sales (Units) of Key Manufacturers (2019-2024)
 Table 5. Global Drug Delivery Soft Mist Inhalers Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Drug Delivery Soft Mist Inhalers Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Drug Delivery Soft Mist Inhalers Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Drug Delivery Soft Mist Inhalers Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Drug Delivery Soft Mist Inhalers, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Delivery Soft Mist Inhalers, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Delivery Soft Mist Inhalers, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Delivery Soft Mist Inhalers, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Delivery Soft Mist Inhalers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Soft Mist Inhalers as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Delivery Soft Mist Inhalers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Drug Delivery Soft Mist Inhalers Sales by Region (2019-2024) & (Units)
 Table 18. Global Drug Delivery Soft Mist Inhalers Sales Market Share by Region (2019-2024)
 Table 19. Global Drug Delivery Soft Mist Inhalers Sales by Region (2025-2030) & (Units)
 Table 20. Global Drug Delivery Soft Mist Inhalers Sales Market Share by Region (2025-2030)
 Table 21. Global Drug Delivery Soft Mist Inhalers Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Region (2019-2024)
 Table 23. Global Drug Delivery Soft Mist Inhalers Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Region (2025-2030)
 Table 25. North America Drug Delivery Soft Mist Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Drug Delivery Soft Mist Inhalers Sales by Country (2019-2024) & (Units)
 Table 27. North America Drug Delivery Soft Mist Inhalers Sales by Country (2025-2030) & (Units)
 Table 28. North America Drug Delivery Soft Mist Inhalers Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Drug Delivery Soft Mist Inhalers Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Drug Delivery Soft Mist Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Drug Delivery Soft Mist Inhalers Sales by Country (2019-2024) & (Units)
 Table 32. Europe Drug Delivery Soft Mist Inhalers Sales by Country (2025-2030) & (Units)
 Table 33. Europe Drug Delivery Soft Mist Inhalers Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Drug Delivery Soft Mist Inhalers Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Drug Delivery Soft Mist Inhalers Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Drug Delivery Soft Mist Inhalers Sales by Region (2019-2024) & (Units)
 Table 37. Asia Pacific Drug Delivery Soft Mist Inhalers Sales by Region (2025-2030) & (Units)
 Table 38. Asia Pacific Drug Delivery Soft Mist Inhalers Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Drug Delivery Soft Mist Inhalers Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Drug Delivery Soft Mist Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Drug Delivery Soft Mist Inhalers Sales by Country (2019-2024) & (Units)
 Table 42. Latin America Drug Delivery Soft Mist Inhalers Sales by Country (2025-2030) & (Units)
 Table 43. Latin America Drug Delivery Soft Mist Inhalers Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Drug Delivery Soft Mist Inhalers Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Drug Delivery Soft Mist Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Drug Delivery Soft Mist Inhalers Sales by Country (2019-2024) & (Units)
 Table 47. Middle East and Africa Drug Delivery Soft Mist Inhalers Sales by Country (2025-2030) & (Units)
 Table 48. Middle East and Africa Drug Delivery Soft Mist Inhalers Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Drug Delivery Soft Mist Inhalers Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Drug Delivery Soft Mist Inhalers Sales (Units) by Type (2019-2024)
 Table 51. Global Drug Delivery Soft Mist Inhalers Sales (Units) by Type (2025-2030)
 Table 52. Global Drug Delivery Soft Mist Inhalers Sales Market Share by Type (2019-2024)
 Table 53. Global Drug Delivery Soft Mist Inhalers Sales Market Share by Type (2025-2030)
 Table 54. Global Drug Delivery Soft Mist Inhalers Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Drug Delivery Soft Mist Inhalers Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Type (2019-2024)
 Table 57. Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Type (2025-2030)
 Table 58. Global Drug Delivery Soft Mist Inhalers Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Drug Delivery Soft Mist Inhalers Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Drug Delivery Soft Mist Inhalers Sales (Units) by Application (2019-2024)
 Table 61. Global Drug Delivery Soft Mist Inhalers Sales (Units) by Application (2025-2030)
 Table 62. Global Drug Delivery Soft Mist Inhalers Sales Market Share by Application (2019-2024)
 Table 63. Global Drug Delivery Soft Mist Inhalers Sales Market Share by Application (2025-2030)
 Table 64. Global Drug Delivery Soft Mist Inhalers Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Drug Delivery Soft Mist Inhalers Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Application (2019-2024)
 Table 67. Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Application (2025-2030)
 Table 68. Global Drug Delivery Soft Mist Inhalers Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Drug Delivery Soft Mist Inhalers Price (US$/Unit) by Application (2025-2030)
 Table 70. Recipharm (Resyca) Company Information
 Table 71. Recipharm (Resyca) Description and Business Overview
 Table 72. Recipharm (Resyca) Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Recipharm (Resyca) Drug Delivery Soft Mist Inhalers Product
 Table 74. Recipharm (Resyca) Recent Developments/Updates
 Table 75. Boehringer Company Information
 Table 76. Boehringer Description and Business Overview
 Table 77. Boehringer Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Boehringer Drug Delivery Soft Mist Inhalers Product
 Table 79. Boehringer Recent Developments/Updates
 Table 80. Merxin Ltd Company Information
 Table 81. Merxin Ltd Description and Business Overview
 Table 82. Merxin Ltd Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Merxin Ltd Drug Delivery Soft Mist Inhalers Product
 Table 84. Merxin Ltd Recent Developments/Updates
 Table 85. DSB Medical Co., Ltd. Company Information
 Table 86. DSB Medical Co., Ltd. Description and Business Overview
 Table 87. DSB Medical Co., Ltd. Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. DSB Medical Co., Ltd. Drug Delivery Soft Mist Inhalers Product
 Table 89. DSB Medical Co., Ltd. Recent Developments/Updates
 Table 90. Aero Pump GmbH Company Information
 Table 91. Aero Pump GmbH Description and Business Overview
 Table 92. Aero Pump GmbH Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Aero Pump GmbH Drug Delivery Soft Mist Inhalers Product
 Table 94. Aero Pump GmbH Recent Developments/Updates
 Table 95. Ursatec GmbH Company Information
 Table 96. Ursatec GmbH Description and Business Overview
 Table 97. Ursatec GmbH Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Ursatec GmbH Drug Delivery Soft Mist Inhalers Product
 Table 99. Ursatec GmbH Recent Developments/Updates
 Table 100. 3M Company Information
 Table 101. 3M Description and Business Overview
 Table 102. 3M Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. 3M Drug Delivery Soft Mist Inhalers Product
 Table 104. 3M Recent Developments/Updates
 Table 105. Hovione Company Information
 Table 106. Hovione Description and Business Overview
 Table 107. Hovione Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Hovione Drug Delivery Soft Mist Inhalers Product
 Table 109. Hovione Recent Developments/Updates
 Table 110. Mannkind Company Information
 Table 111. Mannkind Description and Business Overview
 Table 112. Mannkind Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Mannkind Drug Delivery Soft Mist Inhalers Product
 Table 114. Mannkind Recent Developments/Updates
 Table 115. Meda Company Information
 Table 116. Meda Description and Business Overview
 Table 117. Meda Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Meda Drug Delivery Soft Mist Inhalers Product
 Table 119. Meda Recent Developments/Updates
 Table 120. Novartis Company Information
 Table 121. Novartis Description and Business Overview
 Table 122. Novartis Drug Delivery Soft Mist Inhalers Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Novartis Drug Delivery Soft Mist Inhalers Product
 Table 124. Novartis Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Drug Delivery Soft Mist Inhalers Distributors List
 Table 128. Drug Delivery Soft Mist Inhalers Customers List
 Table 129. Drug Delivery Soft Mist Inhalers Market Trends
 Table 130. Drug Delivery Soft Mist Inhalers Market Drivers
 Table 131. Drug Delivery Soft Mist Inhalers Market Challenges
 Table 132. Drug Delivery Soft Mist Inhalers Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Delivery Soft Mist Inhalers
 Figure 2. Global Drug Delivery Soft Mist Inhalers Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Drug Delivery Soft Mist Inhalers Market Share by Type: 2023 & 2030
 Figure 4. Disposable Product Picture
 Figure 5. Reusable Product Picture
 Figure 6. Global Drug Delivery Soft Mist Inhalers Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Drug Delivery Soft Mist Inhalers Market Share by Application: 2023 & 2030
 Figure 8. Hospitals and Clinics
 Figure 9. Homecare Settings
 Figure 10. Others
 Figure 11. Global Drug Delivery Soft Mist Inhalers Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Drug Delivery Soft Mist Inhalers Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Drug Delivery Soft Mist Inhalers Sales (2019-2030) & (Units)
 Figure 14. Global Drug Delivery Soft Mist Inhalers Average Price (US$/Unit) & (2019-2030)
 Figure 15. Drug Delivery Soft Mist Inhalers Report Years Considered
 Figure 16. Drug Delivery Soft Mist Inhalers Sales Share by Manufacturers in 2023
 Figure 17. Global Drug Delivery Soft Mist Inhalers Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Drug Delivery Soft Mist Inhalers Players: Market Share by Revenue in Drug Delivery Soft Mist Inhalers in 2023
 Figure 19. Drug Delivery Soft Mist Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Drug Delivery Soft Mist Inhalers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Drug Delivery Soft Mist Inhalers Sales Market Share by Country (2019-2030)
 Figure 22. North America Drug Delivery Soft Mist Inhalers Revenue Market Share by Country (2019-2030)
 Figure 23. United States Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Drug Delivery Soft Mist Inhalers Sales Market Share by Country (2019-2030)
 Figure 26. Europe Drug Delivery Soft Mist Inhalers Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Drug Delivery Soft Mist Inhalers Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Drug Delivery Soft Mist Inhalers Revenue Market Share by Region (2019-2030)
 Figure 34. China Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Drug Delivery Soft Mist Inhalers Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Drug Delivery Soft Mist Inhalers Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Drug Delivery Soft Mist Inhalers Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Drug Delivery Soft Mist Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Drug Delivery Soft Mist Inhalers by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Drug Delivery Soft Mist Inhalers by Type (2019-2030)
 Figure 53. Global Drug Delivery Soft Mist Inhalers Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Drug Delivery Soft Mist Inhalers by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Drug Delivery Soft Mist Inhalers by Application (2019-2030)
 Figure 56. Global Drug Delivery Soft Mist Inhalers Price (US$/Unit) by Application (2019-2030)
 Figure 57. Drug Delivery Soft Mist Inhalers Value Chain
 Figure 58. Drug Delivery Soft Mist Inhalers Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Oxygen Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11D3386
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D2937
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Bronchiectasis Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18E6080
Mon Sep 08 00:00:00 UTC 2025

Add to Cart